U.S. Markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.04
    -1.53 (-2.86%)
     
  • Gold

    1,827.70
    -23.70 (-1.28%)
     
  • Silver

    24.83
    -0.97 (-3.77%)
     
  • EUR/USD

    1.2085
    -0.0079 (-0.6526%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • Vix

    24.34
    +1.09 (+4.69%)
     
  • GBP/USD

    1.3583
    -0.0057 (-0.4143%)
     
  • USD/JPY

    103.8710
    +0.0290 (+0.0279%)
     
  • BTC-USD

    37,500.41
    +482.12 (+1.30%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.12 (-0.62%)
     

Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.1 million of Shares

GuruFocus.com
·2 min read

- By insider

CEO of Moderna Inc (30-Year Financial, Insider Trades) Stephane Bancel (insider trades) sold 10,000 shares of MRNA on 12/31/2020 at an average price of $110.55 a share. The total sale was $1.1 million.


Moderna Inc has a market cap of $44.21 billion; its shares were traded at around $111.730000 with and P/S ratio of 174.58. GuruFocus has detected 5 severe warning signs with Moderna Inc. .

CEO Recent Trades:

  • CEO Stephane Bancel sold 10,000 shares of MRNA stock on 12/31/2020 at the average price of $110.55. The price of the stock has increased by 1.07% since.

  • CEO Stephane Bancel sold 9,000 shares of MRNA stock on 12/30/2020 at the average price of $118.27. The price of the stock has decreased by 5.53% since.

  • CEO Stephane Bancel sold 11,046 shares of MRNA stock on 12/28/2020 at the average price of $116.44. The price of the stock has decreased by 4.05% since.

  • CEO Stephane Bancel sold 19,000 shares of MRNA stock on 12/24/2020 at the average price of $123.16. The price of the stock has decreased by 9.28% since.

  • CEO Stephane Bancel sold 15,775 shares of MRNA stock on 12/21/2020 at the average price of $140.06. The price of the stock has decreased by 20.23% since.

Directors and Officers Recent Trades:

  • Chief Medical Officer Tal Zvi Zaks sold 1,200 shares of MRNA stock on 12/28/2020 at the average price of $116.27. The price of the stock has decreased by 3.9% since.

  • President Stephen Hoge sold 15,000 shares of MRNA stock on 12/24/2020 at the average price of $124.48. The price of the stock has decreased by 10.24% since.

  • Chief Medical Officer Tal Zvi Zaks sold 17,129 shares of MRNA stock on 12/21/2020 at the average price of $142.59. The price of the stock has decreased by 21.64% since.

  • President Stephen Hoge sold 20,000 shares of MRNA stock on 12/14/2020 at the average price of $163.63. The price of the stock has decreased by 31.72% since.

  • Chief Medical Officer Tal Zvi Zaks sold 25,034 shares of MRNA stock on 12/14/2020 at the average price of $157.81. The price of the stock has decreased by 29.2% since.

For the complete insider trading history of MRNA, click here

.This article first appeared on GuruFocus.